HM12460A

BIOLOGICAL3 trials

Sponsors

Hanmi Pharmaceutical Company Limited

Conditions

HealthyHealthy VolunteersType 1 Diabetes MellitusType 2 Diabetes Mellitus

Phase 1

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A

CompletedNCT01724814

Hanmi Pharmaceutical Company LimitedHealthy, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Start: 2012-12-20End: 2014-07-01Updated: 2017-11-08

Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus

TerminatedNCT03332836

Hanmi Pharmaceutical Company LimitedType 2 Diabetes Mellitus

Start: 2017-10-25End: 2020-09-30Updated: 2021-04-01

Molar Potency Study of HM12460A in Healthy Subjects

CompletedNCT03330314

Hanmi Pharmaceutical Company LimitedHealthy Volunteers

Start: 2017-10-24End: 2018-02-08Updated: 2020-08-12